Skip to Main Content

Paper Details

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer.
PLoS One
6
2020
AR, BRCA1/2, BRCA2, CONCLUSION HR gene, HR, HR gene, HR repair, HR repair gene, HR repair genes, PALB2 mutations, PARP, PSA, PSA30, PSA50, androgen, androgen receptor, germline, homologous recombination, homologous recombination (HR) repair genes, homologous recombination repair genes, mCRPC, metastatic castration resistant prostate cancer, metastatic castration-resistant prostate cancer, patients, platinum, poly(ADP-ribose), poly(ADP-ribose) polymerase, prostate-specific antigen, taxane, tumor
Author NameAffiliation
Heather H ChengUniversity of Washington
Heather H ChengDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Bruce MontgomeryUniversity of Washington
Bruce MontgomeryDivision of Clinical Research, Fred Hutchinson Cancer Research Center
Evan Y YuUniversity of Washington
Evan Y YuDivision of Clinical Research, Fred Hutchinson Cancer Research Center
  • 1 - 14

Datasets

Release 1.2